H2 antagonists, proton pump inhibitors and COVID-19.
Published in Journal of anesthesia
H2 antagonists, proton pump inhibitors and COVID-19.
Cefepime-induced encephalopathy in a COVID-19 patient: a case report.
Published in Journal of anesthesia
Prolonged neurological symptoms such as "brain fog" and cognitive impairment have occurred after coronavirus disease 2019 (COVID-19) infection. In this report, we describe impaired consciousness caused by cefepime hydrochloride (CFPM) in a patient with cognitive sequalae of COVID-19. A 56-year-old male patient was diagnosed with penile abscess afte...
Underestimating hypoactive delirium?
Published in Journal of anesthesia
Double-C hold for bag-mask ventilation during resuscitation.
Published in Journal of anesthesia
Emergence agitation or delirium in children.
Published in Journal of anesthesia
Is there a role for pregabalin as premedication in pediatric anesthesia?
Published in Journal of anesthesia
Correction to: Evaluation of gastric contents using ultrasound in full-term pregnant women fasted for 8 h: a prospective...
Published in Journal of anesthesia
Reply to the letter titled "Difficulty in evaluating the effect of CEA or CRSB".
Published in Journal of anesthesia
Does the oxygen reserve index play a role in oxygen therapy?
Published in Journal of anesthesia
Effect of chlorpheniramine administration on postoperative catheter-related bladder discomfort in patients undergoing tr...
Published in Journal of anesthesia
Catheter-related bladder discomfort (CRBD) is postoperative distress caused by a urinary catheter. CRBD is related to muscarinic receptor activation. Chlorpheniramine has antimuscarinic properties. Hence, this investigation was undertaken to evaluate the efficacy of chlorpheniramine in preventing CRBD in patients undergoing transurethral resection ...
